Summary & Overview
CPT 0207T: Thermal and Pressure Treatment for Meibomian Gland Dysfunction
CPT code 0207T denotes a therapeutic ophthalmic procedure using thermal energy combined with pressure to treat meibomian gland dysfunction (MGD), a common cause of evaporative dry eye. The code captures a technology-driven, office- or ambulatory-based intervention aimed at restoring gland expressibility and improving tear film stability. Nationally, this code matters as MGD-related dry eye contributes substantially to patient morbidity, increases outpatient procedure utilization, and has implications for coverage policy and clinical pathway development.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how the procedure is defined clinically and operationally, insights into where the service is typically delivered, and expectations for documentation and coding alignment. The publication summarizes available benchmarks and payment context, highlights relevant clinical considerations for patient selection, and outlines common administrative elements associated with billing and claims submission.
This national summary is intended for health policy analysts, billing professionals, and clinical leaders seeking a concise reference on CPT code 0207T, its clinical role in managing dry eye from MGD, and the payer landscape relevant to coverage and reimbursement discussions.
Billing Code Overview
CPT code 0207T describes a procedure in which the provider uses thermal energy and pressure to treat meibomian gland dysfunction that causes dry eye syndrome. The service type is a therapeutic ophthalmic procedure targeting the meibomian glands of the eyelids to restore gland function and improve tear film quality.
The typical site of service for CPT code 0207T is an outpatient ophthalmology or eye care clinic, ambulatory surgical center, or other facility where office-based eye procedures are performed.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient presents to an ophthalmology clinic with chronic symptoms of ocular irritation, burning, fluctuating vision, and contact lens intolerance despite optimized artificial tears and lid hygiene. The history and ocular surface exam reveal evidence of meibomian gland dysfunction (MGD) with meibomian gland obstruction, lid telangiectasia, frothy tear film, and reduced tear breakup time consistent with evaporative dry eye syndrome. After conservative measures (warm compresses, lid scrubs, omega-3 supplementation) and a trial of topical anti-inflammatory therapy, the clinician elects in-office thermal and expression treatment targeting meibomian gland orifices.
The clinical workflow: the patient is consented and prepped in an outpatient ophthalmology procedure room. Topical anesthesia and antisepsis are applied. A device that applies controlled thermal energy and simultaneous pressure to the eyelids is used to heat meibomian glands and express obstructed contents. The provider documents pre-procedure evaluation, device settings, treatment duration per eye, any complications, and post-procedure instructions. Follow-up visits assess symptom improvement, gland function, and need for repeat treatment. Typical site of service is an outpatient ophthalmology clinic or ambulatory surgery center. Service type is a physician-directed in-office therapeutic procedure for meibomian gland dysfunction using thermal energy and pressure, billed with 0207T.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard billing | Use when no special modifier applies and service is routine. |
22 | Increased procedural services | Use when complexity or time significantly exceeds typical and documentation supports increased work. |
23 | Unusual anesthesia | Use if general anesthesia or deep sedation was required and is documented as medically necessary. |
52 | Reduced services | Use when the procedure is partially reduced or not completed as originally planned. |
53 | Discontinued procedure | Use if the procedure was started but terminated due to extenuating circumstances. |
54 | Surgical care only | Use when another clinician bills pre/postoperative services and you bill only the procedure. |
55 | Postoperative management only | Use when billing only global period follow-up care for the procedure. |
62 | Two surgeons | Use when two surgeons of different specialties perform distinct parts of the procedure together. |
66 | Surgical team | Use when a surgical team approach is documented for complex cases. |
78 | Return to OR for related procedure during global period | Use if a related procedure is performed in the operating room during the global period. |
80 | Assistant surgeon | Use when a surgical assistant is involved and payer accepts assistant surgeon billing. |
81 | Minimum assistant surgeon | Use when minimal assistance is documented and accepted by payer. |
82 | Assistant not available — qualified resident | Use when a qualified resident performs assistant role in absence of qualified assistant. |
73 | Discontinued outpatient hospital/ASC/clinic procedure prior to anesthesia | Use when procedure cancelled after patient preparation but before anesthesia or incision. |
78 | (duplicate omitted) | (duplicate — already listed) |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
207K00000X | Ophthalmology | Comprehensive ophthalmologists commonly perform and supervise this procedure. |
207KB0008X | Oculoplastic Surgery | Oculoplastic surgeons may perform lid-related interventions in complex cases. |
2080P0007X | Optometry | Therapeutic optometrists with procedural privileges may provide in-office gland therapies where allowed. |
363L00000X | Ophthalmic Plastic and Reconstructive Surgery | Providers focusing on eyelid/gland disorders may treat refractory MGD. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
H02.84 | Lid laxity | Eyelid malposition can contribute to meibomian gland dysfunction and poor gland expression. |
H04.11 | Chalazion of upper eyelid | Related eyelid gland pathology; chronic meibomian obstruction can predispose to chalazion formation. |
H16.222 | Exposure keratopathy, bilateral | Severe evaporative dry eye from MGD can lead to corneal exposure changes. |
H04.23 | Obstruction of meibomian gland, bilateral | Direct diagnosis indicating gland obstruction targeted by thermal expression therapy. |
H04.12 | Chalazion of lower eyelid | Lower eyelid gland disease related to MGD presentations. |
H04.121 | Chalazion of right lower eyelid | Site-specific coding when applicable to document laterality. |
H04.122 | Chalazion of left lower eyelid | Site-specific coding when applicable to document laterality. |
H04.2 | Disorder of lacrimal system, unspecified | Broader ocular surface disorder codes used when precise MGD code not chosen. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
99213 | Office or other outpatient visit for the evaluation and management of an established patient, low to moderate complexity | Pre-procedure evaluation and routine follow-up visit for symptom assessment and decision-making. |
99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | Used for more complex pre-procedure assessment or management of comorbid ocular surface disease. |
65435 | Removal of impacted foreign body, external eye; complicated (e.g., requiring sedation) | Not typically routine but may be performed if eyelid pathology requires additional intervention during the same encounter. |
67840 | Reconstructive procedure on eyelid (repair of eyelid defect) | Performed in conjunction when eyelid structural procedures are required for severe gland disease or tumors. |
92083 | Extended ophthalmological services; medical retina evaluation for established patient including scanning computerized ophthalmic diagnostic imaging | Ancillary diagnostic testing for ocular surface or posterior segment when indicated in the same episode of care. |